Lakeisha Keneti
Family · Suffolk, VANPI 1609119452
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $28,050 of the $33,278 with a category attached, or 84.3%. AbbVie accounts for 95.3% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2023 at $16,066 and has fallen 99.3% since, to $110 in 2025. Among family clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 168 payments — averaging $198.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$32K
- Sunovion Pharmaceuticals Inc.$580
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$490
- Alkermes, Inc.$147
- Johnson & Johnson$114
- Neurocrine Biosciences, Inc.$68
- plus $179 from 6 others
What the payments were for
- Speaking & faculty fees$28,05084%
- Travel & lodging$1,7805%
- Food & beverage$3,37610%
- Education$720%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 111 | $31,699 |
| Sunovion Pharmaceuticals Inc. | 24 | $580 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 16 | $490 |
| Alkermes, Inc. | 2 | $147 |
| Johnson & Johnson | 4 | $114 |
| Neurocrine Biosciences, Inc. | 3 | $68 |
| E.r. Squibb & Sons, L.L.C. | 2 | $55 |
| Eisai Inc. | 2 | $36 |
| Vanda Pharmaceuticals Inc. | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$29,844
- ARISTADA$495
- LATUDA$234
- CAPLYTA$132
- ARISTADA INITIO$124
How this compares
$33,278 in reported general payments places this provider in the 95th percentile of 4,332 family providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lamotrigine | 25 | $172 |
Paid to pharmacies, not to this prescriber.
Other family in Suffolk
- Andrea CottonVirginia Beach$696K
- Susan MooreWytheville$438K
- Ellen WermterCharlottesville$251K
- Dana StallingsFranklin$225K
- Jocelyn BrackettHerndon$199K
- Hochong Smith GillesRichmond$131K
- Sean OlaughlinMidlothian$110K
- Adam MedlinHampton$67K
- Casey SharpDanville$63K
- Norman JacobowitzManassas$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.